Skip to main content
. 2017 Sep;9(9):2904–2914. doi: 10.21037/jtd.2017.08.01

Table S5. Pulmonary function tests of patients.

Variables Cluster 1 Cluster 2 Cluster 3 Cluster 4 Total P
FVC% pred 81.5 (16.2) 83.6 (14.7) 80.9 (18.6) 62.5 (14.3) 78.9 (17.6) <0.001
FEV1% pred 68.6 (17.9) 65.6 (17.0) 71.6 (19.8) 39.2 (14.3) 63.5 (20.7) <0.001
FEV1/FVC 71.3 (12.0) 63.5 (11.0) 73.0 (9.4) 50.3 (13.6) 65.7 (13.8) <0.001
MMEF% pred 44.8 (22.5) 39 (18.5) 45.3 (26.0) 18.6 (16.1) 38.8 (23.1) <0.001
MEF25%% pred 40.4 (25.5–58.3) 32.8 (23.4–48.7) 43.8 (28.4–59.9) 16.5 (13.4–24.7) 34.2 (22.9–50.6) <0.001
MEF50%% pred 44.6 (22.3) 39.1 (19.7) 44.1 (25.0) 17.9 (17.2) 38.3 (23.3) <0.001
MEF75%% pred 51.5 (21.4) 44.4 (21.2) 53.3 (22.2) 20.6 (16.9) 44.5 (23.6) <0.001
RV/TLC 44.2 (10.7) 45.2 (9.9) 49.3 (10.0) 55.2 (10.0) 47.7 (10.8) <0.001
R4-R24 0.49 (0.24–1.03) 0.74 (0.36–1.21) 0.78 (0.25–1.29) 1.39 (0.65–1.93) 0.76 (0.33–1.36) <0.05
FeNO 24.2 (14.2–43.1) 26 (15–67.2) 18.3 (14–57.1) 24 (9.6–41) 23.5 (14–50.7) 0.545
Post FEV1% pred 73.8 (17.9) 74.8 (19.0) 79.4 (20.2) 44.0 (14.9) 70.6 (22.0) <0.001
Post FVC% pred 86.0 (16.1) 90.0 (15.8) 87.3 (18.4) 69.7 (14.6) 84.9 (17.7) <0.001
Post FEV1/FVC 72.6 (12.7) 65.6 (13.8) 75.4 (8.8) 48.8 (16.0) 67.1(15.6) <0.001
Change in FEV1 (L) 0.12 (0.04–0.27) 0.26 (0.08–0.41) 0.13 (0.04–0.25) 0.13 (0.05–0.21) 0.16 (0.06–0.29) <0.05

Data are presented as the mean (SD) or median (IOR). P value from one-way ANOVA and nonparametric test (Kruskal-Wallis) among the four clusters. FVC% pred, forced vital capacity% predicted; FEV1% pred, forced expiratory volume in the first second% predicted; FEV1/FVC, ratio of forced expiratory volume in the first second to forced vital capacity; RV, residual volume; TLC, total lung capacity; MMEF% pred, maximal mid-expiratory flow% predicted; MEF25%, maximal expiratory flow in 25% vital capacity; MEF50%, maximal expiratory flow in 50% vital capacity; MEF75%, maximal expiratory flow in 75% vital capacity; FeNO, fraction of expired nitric oxide.